Special Issue "Cancer Treatment: Clinical Applications of Cell Cultures"
Deadline for manuscript submissions: closed (15 August 2021).
Since their development at the end of the 19th/beginning of the 20th century, cell cultures have been the preferred technique for research in almost every biomedical field. Cell cultures involve cell isolation from their primary (natural) environment (from animals and/or patients) and the subsequent adaptation of these cells to grow in a controlled artificial environment (in vitro growth). One of the major advantages of this method is that cell cultures, to a great extent, keep the features of the natural environment (tissue and disease) from which they have been derived. Cells from specific living tissues, whether normal or diseased, can be cultured either as short-term or longer-term cultures (e.g., established cell lines). It is well known that the great advances and progress in biomedicine could not have been achieved without the use of cultured cells. However, it is not only research that has benefitted from cell cultures: diagnosis and the development of new therapies for deadly human diseases have been based on the use of cell cultures. Regenerative medicine, in vitro fertilization, and even precision medicine in cancer and current cancer immunotherapies are some clinical fields that have been advanced based on cell culture techniques saving and/or largely improving the quality of life of innumerous patients. In this context, this Special Issue of Medicina is dedicated to clinical applications of cell cultures for the treatment of cancer. We aim to host a unique collection of papers that will provide researchers with cutting-edge research and critical information on the potential role of cell cultures in the war against cancer.
Dr. Konstantinos Dimas
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1500 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Precision medicine
- Primary cells
- Patient-derived cells
- Cancer stem cells